ATE471153T1 - Verwendung eines bakterienlysats zur verhinderung eines tuberkuloserückfalls - Google Patents

Verwendung eines bakterienlysats zur verhinderung eines tuberkuloserückfalls

Info

Publication number
ATE471153T1
ATE471153T1 AT05707259T AT05707259T ATE471153T1 AT E471153 T1 ATE471153 T1 AT E471153T1 AT 05707259 T AT05707259 T AT 05707259T AT 05707259 T AT05707259 T AT 05707259T AT E471153 T1 ATE471153 T1 AT E471153T1
Authority
AT
Austria
Prior art keywords
recirculation
bacterial lysate
prevent tuberculosis
tuberculosis
prevent
Prior art date
Application number
AT05707259T
Other languages
English (en)
Inventor
Nataliya Dyachyk
Original Assignee
Parmeggiani Francesco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parmeggiani Francesco filed Critical Parmeggiani Francesco
Application granted granted Critical
Publication of ATE471153T1 publication Critical patent/ATE471153T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT05707259T 2005-02-08 2005-02-08 Verwendung eines bakterienlysats zur verhinderung eines tuberkuloserückfalls ATE471153T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2005/001256 WO2006084477A1 (en) 2005-02-08 2005-02-08 Use of a lyophilised bacterial lysate for the prevention of tuberculosis relapse

Publications (1)

Publication Number Publication Date
ATE471153T1 true ATE471153T1 (de) 2010-07-15

Family

ID=35079444

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05707259T ATE471153T1 (de) 2005-02-08 2005-02-08 Verwendung eines bakterienlysats zur verhinderung eines tuberkuloserückfalls

Country Status (4)

Country Link
EP (1) EP1848448B8 (de)
AT (1) ATE471153T1 (de)
DE (1) DE602005021924D1 (de)
WO (1) WO2006084477A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20061117A1 (it) * 2006-06-09 2007-12-10 Michele Bonanomi Una composizione farmaceutica per la somministrazione sublinguale di vaccini metodo per la sua preparazione e sui usi
SI2114421T1 (en) 2007-03-05 2018-04-30 Om Pharma A bacterial extract for respiratory disorders and a process for its preparation

Also Published As

Publication number Publication date
EP1848448B8 (de) 2010-09-15
EP1848448B1 (de) 2010-06-16
DE602005021924D1 (de) 2010-07-29
WO2006084477A1 (en) 2006-08-17
EP1848448A1 (de) 2007-10-31

Similar Documents

Publication Publication Date Title
NZ594207A (en) Immediate release composition resistant to abuse by intake of alcohol
MX345158B (es) Formulaciones de fluoroquinolona en aerosol para farmacocinetica mejorada.
TW200716200A (en) Methods of reducing microbial contamination
MX336260B (es) Composiciones para el tratamiento de infecciones de pulmon, formuladas para ser administrables mediante aerolizacion, y que incluyen tobramicina.
CL2012001080A1 (es) Dispersión sólida de rifaximina y un portador farmacéuticamente aceptable; composición farmacéutica; uso en el tratarmiento y/o prevención de una infecciíon microbiana que comprende la administración de la dipersión sólida.
WO2009036000A3 (en) Methods of treating a microbial infection by modulating rnase-l expression and/or activity
ZA200807879B (en) Use of bifidobacterium longum for the prevention and treatment of inflammation
WO2005089738A3 (en) Use and administration of bacterial efflux pump inhibitors
WO2006013441A3 (en) Use of probiotic bacteria for the preparation of topical compositions for skin protection
WO2010004433A3 (en) Hydrophobically enhanced aminoglycosides
ATE354964T1 (de) Probiotische zusammensetzung mit mindestens zwei milchsäurebakterienstämmen, die zur kolonisierung des magen-darm-trakts fähig sind und in kombination damit die eigenschaften, im darm zu überleben, an den darm zu binden, gegen infektion zu schützen und ballaststoffe zu fermentieren, aufweisen
MX2011012161A (es) Ensamble de puerto de acceso respiratorio con cierre pasivo y metodo de uso.
WO2010054083A3 (en) Inhalation formulation for treating and prophylatic use in bacteria, mycobacterial and fungal respiratory infections
CL2012003168A1 (es) Composicion farmaceutica que comprende una solucion acuosa de minociclina y un cation divalente o trivalente en una proporcion mayor de 2:1 con respecto a la minociclina; metodo de preparacion; kit y uso en el tratamiento de infecciones bacterianas.
MX342226B (es) Uso de streptococcus salivarius en el tratamiento de infecciones cronicas del tracto respiratorio.
IN2012DN01414A (de)
WO2009090082A3 (de) Bakteriophagenpräparation und verwendung
WO2008071961A8 (en) 2-quinolinone and 2-quinoxalinone- derivatives and their use as antibacterial agents
ATE471153T1 (de) Verwendung eines bakterienlysats zur verhinderung eines tuberkuloserückfalls
CL2008001613A1 (es) Compuestos macrociclicos; composicion farmaceutica; y uso en el tratamiento de una infeccion bacteriana.
WO2008101052A3 (en) Compositions and methods for treating, reducing, ameliorating, or preventing infections of the ear or upper respiratory tract
EA200801890A1 (ru) Средство для лечения шума в ушах
RU2007108834A (ru) Способ профилактики эндометритов коров
DK1880727T3 (da) Topisk vaginal farmaceutiske sammensætninger
MY139425A (en) Pharmaceutical composition comprising 2,4-dichlorobenzyl alcohol and amylmetacresol

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties